Davis Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Davis Investment Partners's AMGN Position: Q2 2026 in Review
Davis Investment Partners reduced its Amgen (AMGN) stake by 0.24% in Q2 2026, selling an estimated $3.77K and leaving 4,600 shares worth $1.67M. The position accounts for 0.51% of the portfolio, ranked #34.
Davis Investment Partners first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Davis Investment Partners held 4,600 shares of Amgen worth $1.67M as of Q2 2026.
- Davis Investment Partners sold 11 Amgen shares in Q2 2026, an estimated $3.77K.
- Amgen made up 0.51% of Davis Investment Partners's portfolio in Q2 2026, its #34 holding.
- Davis Investment Partners first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Davis Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.